Connect with us

National

Clover Biopharma’s new trimeric subunit vaccine candidate prevents COVID-19 in monkeys – News-Medical.Net

The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the preprint server bioRxiv.

Published

on

Researchers from Clover Biopharmaceuticals, the Chinese Academy of Sciences, and China’s National Institutes for Food and Drug Control (NIFDC) report a trimeric subunit vaccine candidate similar to the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the…

Click here to view the original article.